tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market

Pharmarise Holdings Corp. (2796) Income Statement

Compare
0 Followers

Pharmarise Holdings Corp. Income Statement

Last quarter (Q2 2024), Pharmarise Holdings Corp.'s total revenue was ¥15.31B, an increase of 13.62% from the same quarter last year. In Q2, Pharmarise Holdings Corp.'s net income was ¥17.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
¥ 54.47B¥ 52.03B¥ 51.61B¥ 52.32B¥ 51.03B
Gross Profit
¥ 8.45B¥ 8.13B¥ 8.12B¥ 8.07B¥ 7.44B
Operating Expenses
¥ 7.53B¥ 6.70B¥ 6.60B¥ 6.82B¥ 6.40B
Depreciation and Amortization
¥ 1.17B¥ 1.22B¥ 1.31B¥ 1.34B¥ 1.23B
EBITDA
¥ 1.38B¥ 2.66B¥ 2.83B¥ 2.59B¥ 2.26B
Operating Income
¥ 916.00M¥ 1.44B¥ 1.52B¥ 1.25B¥ 1.03B
Other Income/Expenses
¥ -773.00M¥ -389.00M¥ -198.00M¥ -44.00M¥ -215.00M
Pretax Income
¥ 143.00M¥ 1.05B¥ 1.32B¥ 1.20B¥ 819.00M
Net Income
¥ -351.00M¥ 333.00M¥ 447.00M¥ 426.00M¥ 577.00M
Per Share Metrics
Basic EPS
¥ -33.35¥ 35.42¥ 47.90¥ 45.78¥ 61.03
Diluted EPS
¥ -33.35¥ 26.86¥ 36.22¥ 34.59¥ 46.32
Weighted Average Shares Outstanding
10.52M 9.40M 9.33M 9.31M 9.45M
Weighted Average Shares Outstanding (Diluted)
10.52M 12.47M 12.40M 12.37M 12.50M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis